ESOXX

Medical device with mechanical action that quickly reduces symptoms related to gastro-esophageal reflux such as: pyrosis, epigastric pain, acid regurgitation, irritative cough, disphony.
The Gastro-esophageal Reflux Disease, often abbreviated as MRGE (in English GERD, Gastro-Esophageal Reflux Disease), is characterized by symptoms (pyrosis, acid regurgitation, irritative cough, disfagia) that may be associated with erosive inflammatory injuries of the esophageal mucosa. MRGE is usually exacerbated by supine position, so symptoms can be accentuated during night rest.
ESOXX is an association of hyaluronic acid and condroitin-solfato, able to exercise a mechanism of defense of the original and innovative gastro-esophageal mucosa. The presence in the formulation of a high-capacity bioadhesive component (poloxamer 407), favoring the permanence of contact with the surface of the esophageal wall of hyaluronic acid and chondroitin-sulphate, contributes to the protective effect towards the action of hydrochloric acid produced by the stomach. The condroitin-solfato also has a favorable action the repair processes of gastro-esophageal mucosa.

Ingredients
Hyaluronic acid; sulphate condroitine; polyvinylpyrolidone; xylitol C; benzoate sodium; potassium sorbate; aromas; demineralized water; poloxamer 407.

Mode of use
10 ml after main meals and at bedtime or according to medical advice. Shake the bottle before use.

Contraindications
None in particular, except for cases of hypersensitivity to one of its components. In such circumstances, stop the treatment and contact your doctor. Although no side effects are known, it is recommended not to use the product during pregnancy or in the first months of lactation. In any case, consult your doctor first.

Warnings
Do not exceed the recommended dose.
Keep out of reach of children.

Conservation
Store in a cool and dry place and away from heat sources. Don't freeze.

Format
200 ml bottle with dispenser.

CE mark registration number 0373